COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Read our FAQs.
Investigational device for patients with chronic heart failure
Thomas Heywood, M.D.
This study will evaluate the effectiveness of an investigational device for measuring changes in the signs and symptoms heart failure.
Have been diagnosed with heart failure
Be able to give informed consent
Meet all other eligibility requirements
Patients must not:
Have a pacemaker or other implanted cardiac device
Have other medical conditions that would interfere with study participation
Be pregnant or breastfeeding
This study is observational only. There will be no changes to the usual treatment that is given for patients with chronic heart failure.
The investigational device, ImpediMeds SOZO, is a non-invasive fluid monitoring device designed to allow patients with heart failure to monitor their symptoms at home. Participation in the study will require clinic visits 3 days a week (Mon., Wed., and Fri.) for 4 weeks.